Despite positive results nearly across the board, market reception to those reporting earnings remains a bit mixed. We surmise the combination of relatively high valuations and the looming specter of decelerating growth against more challenging comparisons in the quarters to come have prompted some angst among investors.
Read MoreAmid declines in the number of COVID-19 cases across the U.S. and with another round of stimulus on the horizon, investors and management teams alike appear sanguine about the outlook for 2021.
Read MoreOur calendar Q3 ’20 earnings season began with CTG, Inc. (CTG) surpassing Street expectations as the company made further strides in shifting towards a more solutions-centric business.
Read MoreThe calendar Q2 ’20 earnings season is officially underway, and the initial results suggest that business conditions were better than feared at the outset of the COVID-19 pandemic. Brightcove (BCOV) saw the strongest post-print move amongst the group of reporting companies as results significantly outpaced management’s guidance and consensus.
Read MoreIn a week where advising against the ingestion or injection of disinfectants became a necessary PSA, there was some semblance of normalcy given a smattering of M&A and other capital markets activity, as well as the start of another earnings season in the software space.
Read More